naltrexone has been researched along with quinine in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (21.05) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 6 (31.58) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chipkin, RE; Rosecrans, JA | 1 |
| Frenk, H; Rosen, JB | 1 |
| Crebolder, J; Maier, S; Parker, LA; Rennie, M | 1 |
| Cammera, P; Griffiths, W; Swift, RM | 1 |
| Lynch, MR; Porter, JH; Rosecrans, JA | 1 |
| Froehlich, JC; Krishnan-Sarin, S; Li, TK; Portoghese, PS | 1 |
| Leeb, K; Parker, L | 1 |
| Amit, Z; Babinska, I; Campisi, M; Goodwin, FL | 1 |
| Coonfield, DL; Ferraro, FM; Hill, KG; Kaczmarek, HJ; Kiefer, SW | 1 |
| Berridge, KC; Cooper, SJ; Reynolds, SM; Richardson, DK | 1 |
| Badalia, A; Bodnar, RJ; Duenas, SM; Hossain, M; Rotella, FM; Saeed, S; Sclafani, A; Touzani, K | 1 |
| Henderson-Redmond, AN; Lowe, TE; Morgan, DJ; Tian, XB | 1 |
1 review(s) available for naltrexone and quinine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
18 other study(ies) available for naltrexone and quinine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Aversiveness of oral methadone in rats.
Topics: Animals; Choice Behavior; Decision Making; Heroin Dependence; Humans; Male; Methadone; Models, Psychological; Naltrexone; Quinine; Rats; Self Administration; Taste; Time Factors | 1978 |
Suppressant effects of naltrexone on water intake in rats.
Topics: Animals; Body Weight; Depression, Chemical; Drinking Behavior; Female; Naloxone; Naltrexone; Pain; Quinine; Rats; Self Administration; Sensory Thresholds; Time Factors; Water Deprivation | 1979 |
Morphine- and naltrexone-induced modification of palatability: analysis by the taste reactivity test.
Topics: Animals; Arousal; Avoidance Learning; Brain; Dose-Response Relationship, Drug; Male; Morphine; Naltrexone; Quinine; Rats; Receptors, Opioid; Sucrose; Taste; Taste Threshold | 1992 |
False positive urine drug screens from quinine in tonic water.
Topics: Adult; Alcoholism; Heroin; Heroin Dependence; Humans; Male; Middle Aged; Mineral Waters; Naltrexone; Patient Compliance; Quinine | 1989 |
Latent inhibition in the aversion to oral methadone.
Topics: Animals; Avoidance Learning; Extinction, Psychological; Female; Male; Methadone; Naltrexone; Quinine; Rats; Rats, Inbred Strains; Time Factors | 1984 |
The delta 2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference.
Topics: Alcohol Deterrents; Alcohol Drinking; Animals; Brain Chemistry; Male; Naltrexone; Quinine; Rats; Rats, Wistar; Receptors, Opioid, delta | 1995 |
Amphetamine-induced modification of quinine palatability: analysis by the taste reactivity test.
Topics: Animals; Dextroamphetamine; Drinking Behavior; Male; Morphine; Motor Activity; Naltrexone; Pimozide; Quinine; Rats; Rats, Sprague-Dawley; Sucrose; Taste | 1994 |
Effects of naltrexone on the intake of ethanol and flavored solutions in rats.
Topics: Alcohol Drinking; Animals; Beverages; Drinking; Drug Combinations; Ethanol; Male; Naltrexone; Narcotic Antagonists; Quinine; Rats; Rats, Long-Evans; Rats, Wistar; Saccharin; Solutions | 2001 |
Naltrexone modifies the palatability of basic tastes and alcohol in outbred male rats.
Topics: Alcohol Drinking; Animals; Dose-Response Relationship, Drug; Drinking; Male; Naltrexone; Quinine; Rats; Rats, Long-Evans; Sodium Chloride; Sucrose; Taste | 2002 |
Endogenous opioids are necessary for benzodiazepine palatability enhancement: naltrexone blocks diazepam-induced increase of sucrose-'liking'.
Topics: Analysis of Variance; Animals; Behavior, Animal; Benzodiazepines; Diazepam; Food Preferences; Male; Naltrexone; Narcotic Antagonists; Opioid Peptides; Quinine; Rats; Rats, Sprague-Dawley; Solutions; Sucrose; Taste; Taste Threshold; Time Factors | 2005 |
Role of NMDA, opioid and dopamine D1 and D2 receptor signaling in the acquisition of a quinine-conditioned flavor avoidance in rats.
Topics: Animals; Avoidance Learning; Benzazepines; Conditioning, Psychological; Dizocilpine Maleate; Dopamine D2 Receptor Antagonists; Fructose; Male; Naltrexone; Narcotic Antagonists; Quinine; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Saccharin; Signal Transduction; Taste | 2014 |
Increased ethanol drinking in "humanized" mice expressing the mu opioid receptor A118G polymorphism are mediated through sex-specific mechanisms.
Topics: Alcohol Drinking; Alleles; Analgesics, Non-Narcotic; Analysis of Variance; Animals; Choice Behavior; Conditioning, Operant; Dose-Response Relationship, Drug; Ethanol; Female; Genotype; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutagenesis, Site-Directed; Naltrexone; Narcotic Antagonists; Polymorphism, Single Nucleotide; Quinine; Receptors, Opioid, mu; Reflex; Reward; Self Administration; Self Stimulation; Sex Characteristics | 2018 |